Product Information

ATORVASTATIN 10 MG TABLET is a generic product labeled by Quallent Pharmaceuticals Health LLC, priced at $0.0245 per EA under NDC 82009017610. Its NADAC has been published 38 times since Oct 8, 2025.

The Low Outlier badge above means this manufacturer's average price in the ATORVASTATIN CALCIUM market falls below Q1 − 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.

ATORVASTATIN 10 MG TABLET

ATORVASTATIN CALCIUM
$0.0245per EA
Low Outlier

Strength

10 mg/1

NDC

82009017610

Classification

Generic

Dosage Form

TABLET, FILM COATED

Route

ORAL

Last Updated

6/17/2026

Approval Type

Generic (ANDA)

FDA Application

ANDA214344

On Market Since

8/1/2025

Pharmacological Classes

HMG-CoA Reductase Inhibitor
Hydroxymethylglutaryl-CoA Reductase Inhibitors

Price Statistics

The NADAC for ATORVASTATIN 10 MG TABLET has been published 38 times since Oct 8, 2025, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.

Current price$0.0245 per EA
All-time high$0.0258 (Feb 11, 2026)
All-time low$0.0245 (Jun 17, 2026)
52-week high$0.0258
52-week low$0.0245
Median price$0.0250
Average price$0.0251
Largest weekly change+3.6% (Dec 17, 2025)
Weeks tracked38
Tracking sinceOct 8, 2025

Price History

1W

0.0%

1M

-1.8%

3M

-2.9%

6M

-3.7%

1Y

N/A

3Y

N/A

5Y

N/A

All

-1.0%

Generic Alternatives

The matcher finds 10 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 10 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 4% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of ATORVASTATIN 10 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for ATORVASTATIN 10 MG TABLET, manufactured by Quallent Pharmaceuticals Health LLC, is $0.0245 per EA (NDC 82009017610), effective Jun 24, 2026.

How has the price of ATORVASTATIN 10 MG TABLET changed over time?

Over the history we have for it, the NADAC for ATORVASTATIN 10 MG TABLET has held within roughly two percent of its current level. It has been tracked across 38 weekly CMS publications since Oct 8, 2025.

What are the highest and lowest recorded NADAC prices for ATORVASTATIN 10 MG TABLET?

Since Oct 8, 2025, the NADAC for ATORVASTATIN 10 MG TABLET has ranged from a low of $0.0245 (Jun 17, 2026) to a high of $0.0258 (Feb 11, 2026), with a median of $0.0250 per EA.

Are there cheaper alternatives to ATORVASTATIN 10 MG TABLET?

Yes. 10 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, ATORVASTATIN 10 MG TABLET, is $0.0234 per EA — about 4% below ATORVASTATIN 10 MG TABLET.

Who manufactures ATORVASTATIN 10 MG TABLET?

ATORVASTATIN 10 MG TABLET (NDC 82009017610) is labeled by Quallent Pharmaceuticals Health LLC, and CMS classifies it as a generic product.